Dr. Hauser is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
220 Massachusetts Avenue
Cambridge, MA 02139Phone+1 857-772-1540
Summary
- Dr. Thomas Hauser graduated from the University of Chicago Pritzker School of Medicine with honors after studying Chemistry and Physics at Harvard University. He completed internship, residency, and cardiology fellowship at Beth Israel Deaconess Medical Center, with additional training in cardiovascular magnetic resonance. He subsequently obtained training in nuclear cardiology at Brigham and Women’s Hospital and additional experience in cardiac computed tomography at Massachusetts General Hospital. He also received a Master in Medical Science degree from Harvard Medical School and a Master of Public Health degree from the Harvard T. H. Chan School of Public Health. After his training, he joined the faculty of the Cardiovascular Division at Beth Israel Deaconess Medical Center, where he served as Director of Nuclear Cardiology and Assistant Professor of Medicine at Harvard Medicine School. His research interests have been broad, with a general focus on the use of cardiovascular imaging to elucidate cardiovascular pathophysiology including atrial fibrillation and coronary atherosclerosis. He has authored more than 80 original articles, reviews, and book chapters. His work has been funded by both the National Institutes of Health and industry partners. He also frequently served on data safety monitoring and clinical endpoint committees. While at the Beth Israel Deaconess Medical Center, he was a long time member and vice-chair of the Institutional Review Board. He completed a Fellowship in Bioethics at Harvard Medical School and subsequently joined the clinical ethics team, performing ethics consults addressing complicated medical and ethical scenarios. In 2022, Dr. Hauser joined Novartis Institute of Biomedical Research as Director, Translational Medicine for Cardiometabolic Disease, engaged in drug discovery and development with a focus on proof of concept studies. He continues with patient care at Beth Israel Deaconess Medical Center.
Education & Training
- Beth Israel Deaconess Medical CenterFellowship, Cardiovascular Disease, 2000 - 2003
- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1997 - 2000
- University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1997
Certifications & Licensure
- MA State Medical License 1999 - 2026
- NH State Medical License 2024 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 958 citationsRituximab versus Cyclophosphamide in ANCA-Associated Renal VasculitisRachel B Jones, Jan Willem Cohen Tervaert, Thomas H. Hauser, Raashid Luqmani, Matthew D. Morgan
The New England Journal of Medicine. 2010-07-14 - 183 citationsRituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trialRachel B Jones, Shunsuke Furuta, Jan Willem Cohen Tervaert, Thomas H. Hauser, Raashid Luqmani
Annals of the Rheumatic Diseases. 2015-03-04 - 744 citationsEULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis.Max Yates, Richard A. Watts, Ingeborg M. Bajema, Maria C. Cid, Bruno Crestani
Annals of the Rheumatic Diseases. 2016-09-01
Press Mentions
- Office of Information Technology Launches National SearchJanuary 12th, 2021
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: